Research Summary
Heart failure drugs are medications specifically designed to manage and alleviate the symptoms of heart failure, a chronic condition where the heart is unable to pump blood effectively. These drugs aim to improve the heart's pumping function, reduce fluid buildup in the body, and enhance overall cardiovascular performance. Common classes of heart failure drugs include angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and angiotensin II receptor blockers (ARBs). ACE inhibitors and ARBs work to dilate blood vessels, reducing the workload on the heart, while beta-blockers slow down the heart rate and decrease its force of contraction. Diuretics help eliminate excess fluid and salt, alleviating symptoms like edema and shortness of breath. The combination of these medications is often tailored to individual patient needs, providing a comprehensive approach to managing heart failure and improving the quality of life for those affected by this cardiovascular condition. Regular monitoring and adjustment of drug regimens are crucial components of heart failure management to optimize efficacy and minimize potential side effects.
According to DIResearch's in-depth investigation and research, the global Heart Failure Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Heart Failure Drugs include Novartis, Pfizer, AstraZeneca, Hikma, Teva, Cipla, Merck & Co., Amgen, Roche, Mylan, Sun Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Heart Failure Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Heart Failure Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Heart Failure Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Heart Failure Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Heart Failure Drugs Include:
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Mylan
Sun Pharma
Heart Failure Drugs Product Segment Include:
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Heart Failure Drugs Product Application Include:
Reduced Ejection Fraction
Preserved Ejection Fraction
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Heart Failure Drugs Industry PESTEL Analysis
Chapter 3: Global Heart Failure Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Heart Failure Drugs Major Regional Market Size and Forecast Analysis
Chapter 5: Global Heart Failure Drugs Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Heart Failure Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Heart Failure Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Heart Failure Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Heart Failure Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Heart Failure Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Heart Failure Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Heart Failure Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Heart Failure Drugs Market Overview 1.1 Product Definition and Statistical Scope 1.2 Heart Failure Drugs Product by Type 1.2.1 Global Heart Failure Drugs Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 ACEI 1.2.3 Angiotensin II Receptor Blockers 1.2.4 ARNIs 1.2.5 Beta Blockers 1.2.6 Aldosterone Antagonists 1.2.7 Diuretics 1.3 Heart Failure Drugs Product by Application 1.3.1 Global Heart Failure Drugs Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Reduced Ejection Fraction 1.3.3 Preserved Ejection Fraction 1.4 Global Heart Failure Drugs Market Revenue Analysis (2019-2030) 1.5 Heart Failure Drugs Market Development Status and Trends 1.5.1 Heart Failure Drugs Industry Development Status Analysis 1.5.2 Heart Failure Drugs Industry Development Trends Analysis 2 Heart Failure Drugs Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Heart Failure Drugs Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Heart Failure Drugs Market Analysis by Regions 4.1 Heart Failure Drugs Overall Market: 2023 VS 2024 VS 2030 4.2 Global Heart Failure Drugs Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Heart Failure Drugs Revenue and Market Share by Region (2019-2024) 4.2.2 Global Heart Failure Drugs Revenue Forecast by Region (2025-2030) 5 Global Heart Failure Drugs Market Size by Type and Application 5.1 Global Heart Failure Drugs Market Size by Type 5.2 Global Heart Failure Drugs Market Size by Application 6 North America 6.1 North America Heart Failure Drugs Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Heart Failure Drugs Market Size by Type 6.4 North America Heart Failure Drugs Market Size by Application 6.5 North America Heart Failure Drugs Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Heart Failure Drugs Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Heart Failure Drugs Market Size by Type 7.4 Europe Heart Failure Drugs Market Size by Application 7.5 Europe Heart Failure Drugs Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Heart Failure Drugs Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Heart Failure Drugs Market Size by Type 8.4 China Heart Failure Drugs Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Heart Failure Drugs Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Heart Failure Drugs Market Size by Type 9.4 APAC (excl. China) Heart Failure Drugs Market Size by Application 9.5 APAC (excl. China) Heart Failure Drugs Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Heart Failure Drugs Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Heart Failure Drugs Market Size by Type 10.4 Latin America Heart Failure Drugs Market Size by Application 10.5 Latin America Heart Failure Drugs Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Heart Failure Drugs Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Heart Failure Drugs Market Size by Type 11.4 Middle East & Africa Heart Failure Drugs Market Size by Application 11.5 Middle East & Africa Heart Failure Drugs Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Heart Failure Drugs Market Revenue by Key Manufacturers (2020-2024) 12.2 Heart Failure Drugs Competitive Landscape Analysis and Market Dynamic 12.2.1 Heart Failure Drugs Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Novartis 13.1.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Novartis Heart Failure Drugs Product Portfolio 13.1.3 Novartis Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Pfizer 13.2.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Pfizer Heart Failure Drugs Product Portfolio 13.2.3 Pfizer Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 AstraZeneca 13.3.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 AstraZeneca Heart Failure Drugs Product Portfolio 13.3.3 AstraZeneca Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Hikma 13.4.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Hikma Heart Failure Drugs Product Portfolio 13.4.3 Hikma Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Teva 13.5.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Teva Heart Failure Drugs Product Portfolio 13.5.3 Teva Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Cipla 13.6.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Cipla Heart Failure Drugs Product Portfolio 13.6.3 Cipla Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Merck & Co. 13.7.1 Merck & Co. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Merck & Co. Heart Failure Drugs Product Portfolio 13.7.3 Merck & Co. Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Amgen 13.8.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Amgen Heart Failure Drugs Product Portfolio 13.8.3 Amgen Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Roche 13.9.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Roche Heart Failure Drugs Product Portfolio 13.9.3 Roche Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Mylan 13.10.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Mylan Heart Failure Drugs Product Portfolio 13.10.3 Mylan Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Sun Pharma 13.11.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Sun Pharma Heart Failure Drugs Product Portfolio 13.11.3 Sun Pharma Heart Failure Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Heart Failure Drugs Industry Chain Analysis 14.2 Heart Failure Drugs Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Heart Failure Drugs Typical Downstream Customers 14.4 Heart Failure Drugs Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support